Hot Pursuit     27-Jun-22
Alembic Pharmaceuticals Ltd gains for third straight session
Alembic Pharmaceuticals Ltd is quoting at Rs 746.15, up 2.69% on the day as on 12:49 IST on the NSE. The stock is down 25.51% in last one year as compared to a 0.41% spurt in NIFTY and a 13.77% spurt in the Nifty Metal index.

Alembic Pharmaceuticals Ltd is up for a third straight session in a row. The stock is quoting at Rs 746.15, up 2.69% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 1.15% on the day, quoting at 15879.75. The Sensex is at 53333.72, up 1.15%. Alembic Pharmaceuticals Ltd has risen around 1.3% in last one month.

Meanwhile, Nifty Metal index of which Alembic Pharmaceuticals Ltd is a constituent, has risen around 3.05% in last one month and is currently quoting at 12178.4, up 0.88% on the day. The volume in the stock stood at 71350 shares today, compared to the daily average of 85305 shares in last one month.

The benchmark June futures contract for the stock is quoting at Rs 748.05, up 2.85% on the day. Alembic Pharmaceuticals Ltd is down 25.51% in last one year as compared to a 0.41% spurt in NIFTY and a 13.77% spurt in the Nifty Metal index.

The PE of the stock is 17.98 based on TTM earnings ending March 22.

Previous News
  Board of Alembic Pharmaceuticals recommends final dividend
 ( Corporate News - 09-May-24   14:56 )
  Alembic Pharmaceuticals to discuss results
 ( Corporate News - 17-Oct-23   10:13 )
  Alembic Pharmaceuticals receives multiple product approvals from USFDA
 ( Corporate News - 03-Jul-23   09:11 )
  Alembic Pharmaceuticals receives EIR for its oncology unit at Panelav
 ( Corporate News - 06-May-24   08:52 )
  Alembic Pharmaceuticals to hold AGM
 ( Corporate News - 22-Jun-24   17:42 )
  Alembic Pharmaceuticals' subsidiary gets USFDA approval
 ( Hot Pursuit - 12-Apr-22   10:55 )
  Alembic Pharmaceuticals receives USFDA approval for Clarithromycin Tablets
 ( Corporate News - 01-Feb-22   10:52 )
  Alembic Pharmaceuticals consolidated net profit rises 16.78% in the March 2024 quarter
 ( Results - Announcements 09-May-24   15:06 )
  Alembic Pharmaceuticals gains on USFDA nod for bronchoconstriction drug
 ( Hot Pursuit - 11-May-22   12:22 )
  Alembic Pharma subsidiary receives final approval for lidocaine cream
 ( Hot Pursuit - 12-Apr-22   10:57 )
  Alembic Pharma rises after USFDA approval for testosterone drug
 ( Hot Pursuit - 16-Jun-21   11:09 )
Other Stories
  Dhanlaxmi Bank gains as gross advances rises 6% YoY in Q1 FY25
  05-Jul-24   15:27
  HDFC Bank Ltd leads losers in 'A' group
  05-Jul-24   15:00
  Shilpa Medicare sizzles after Unicycive gets positive results in clinical trials of OLC
  05-Jul-24   14:52
  Manugraph India Ltd leads losers in 'B' group
  05-Jul-24   14:45
  NSE SME Nephro Care India rallies on listing day
  05-Jul-24   14:45
  ESAF SFB total deposits jumps 33% YoY in Q1
  05-Jul-24   14:43
  Utkarsh SFB deposits climb 30% YoY in Q1 FY25
  05-Jul-24   14:35
  Volumes soar at Medplus Health Services Ltd counter
  05-Jul-24   14:30
  Financials stocks slide
  05-Jul-24   14:00
  Banking stocks edge lower
  05-Jul-24   14:00
Back Top